Centiva Capital LP lifted its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 59.1% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 97,798 shares of the real estate investment trust's stock after buying an additional 36,324 shares during the period. Centiva Capital LP's holdings in Sabra Health Care REIT were worth $1,820,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of SBRA. Family Firm Inc. bought a new position in shares of Sabra Health Care REIT in the second quarter worth $26,000. Assetmark Inc. lifted its position in Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock valued at $37,000 after acquiring an additional 1,231 shares in the last quarter. GAMMA Investing LLC raised its stake in Sabra Health Care REIT by 40.0% during the 2nd quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock valued at $57,000 after buying an additional 1,052 shares during the last quarter. Harbor Capital Advisors Inc. purchased a new stake in shares of Sabra Health Care REIT in the 3rd quarter worth $78,000. Finally, International Assets Investment Management LLC boosted its holdings in Sabra Health Care REIT by 1,761.0% in the 3rd quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust's stock worth $114,000 after buying an additional 5,776 shares during the period. Hedge funds and other institutional investors own 99.40% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have recently commented on SBRA shares. Scotiabank raised their target price on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research report on Friday, October 11th. Citigroup upgraded shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and boosted their target price for the company from $17.00 to $20.00 in a report on Friday, September 13th. Truist Financial increased their price objective on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Finally, Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $18.71.
Get Our Latest Research Report on SBRA
Sabra Health Care REIT Price Performance
Shares of NASDAQ SBRA traded down $0.02 during midday trading on Wednesday, reaching $18.43. 1,533,046 shares of the company traded hands, compared to its average volume of 2,039,030. The stock's 50-day simple moving average is $18.61 and its 200-day simple moving average is $16.91. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. Sabra Health Care REIT, Inc. has a 12 month low of $12.83 and a 12 month high of $20.03. The firm has a market cap of $4.36 billion, a PE ratio of 44.90, a PEG ratio of 2.31 and a beta of 1.24.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). The firm had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter in the previous year, the firm posted $0.34 EPS. As a group, equities analysts anticipate that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.
Sabra Health Care REIT Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 6.51%. Sabra Health Care REIT's dividend payout ratio is currently 292.68%.
Sabra Health Care REIT Company Profile
(
Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Featured Stories
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.